Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.29%AUDUSD-1.14%GBPCHF+1.04%USDCHF+0.87%GBPCAD+0.84%GBPNZD+0.75%USDTHB+0.71%USDCAD+0.69%EURGBP-0.67%AUDJPY-0.67%GBPJPY+0.65%EURAUD+0.64%NZDUSD-0.61%AUDNZD-0.53%EURUSD-0.52%USDJPY+0.49%AUDCAD-0.48%PLNJPY+0.44%GBPTRY+0.41%NOKJPY+0.34%CHFJPY-0.34%EURCHF+0.34%SGDJPY+0.33%GBPHKD+0.32%AUDCHF-0.30%GBPMXN-0.28%USDTRY+0.28%NZDCHF+0.27%CADJPY-0.19%CADCHF+0.18%GBPZAR+0.18%EURZAR+0.17%EURCAD+0.17%USDCNH-0.17%USDZAR+0.16%USDILS+0.16%USDMXN+0.15%GBPUSD+0.15%EURNZD+0.10%NZDJPY-0.10%EURSGD+0.09%GBPSGD+0.09%EURNOK+0.09%EURSEK+0.09%CHFSGD+0.08%NZDCAD+0.08%CHFNOK+0.08%USDSGD+0.08%CHFSEK+0.07%AUDSGD+0.07%USDSEK+0.07%USDNOK+0.07%NZDMXN+0.06%AUDNOK+0.06%EURCNH+0.04%USDCOP-0.04%USDHKD+0.04%EURJPY-0.03%USDPLN-0.03%AUDDKK-0.03%USDDKK-0.02%EURPLN-0.01%EURCZK-0.01%EURHKD+0.01%NZDSGD0.00%EURDKK0.00%XAGUSD+0.56%GAGUSD+0.56%HG1-0.36%USOIL-0.25%XPTUSD-0.23%S1-0.21%W1+0.15%C1+0.13%COTTON+0.09%XAUUSD+0.08%GAUUSD+0.08%XNGUSD-0.08%BTCUSD-0.16%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.98%ZECUSDT+0.20%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.86%XLMUSD+2.50%BCHUSDT-0.35%UNIUSD-0.16%LTCUSD+0.07%SUIUSD+2.15%HBARUSDT+1.57%TONUSD+15.77%TAOUSDT+0.01%AAVEUSD-2.54%DOTUSDT+2.78%ICPUSDT-2.19%ONDOUSDT+0.77%WLDUSDT+10.51%ARBUSDT-0.37%JUPUSDT-0.81%ATOMUSDT+1.10%INJUSDT-3.27%STXUSDT+18.33%FETUSDT+3.24%SEIUSDT+0.33%PYTHUSDT-2.99%TIAUSDT-0.52%IMXUSDT+0.97%GRTUSDT-0.30%OPUSDT-0.24%WIFUSDT+3.04%IOTAUSDT+3.16%POLUSDT-4.48%AXSUSDT+0.67%FARTCOINUSDT-0.15%EOSUSDT+3.86%DYDXUSDT+3.30%GALAUSDT+4.75%ORDIUSDT+1.19%NOTUSDT+1.55%RONINUSDT+0.06%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.29%AUDUSD-1.14%GBPCHF+1.04%USDCHF+0.87%GBPCAD+0.84%GBPNZD+0.75%USDTHB+0.71%USDCAD+0.69%EURGBP-0.67%AUDJPY-0.67%GBPJPY+0.65%EURAUD+0.64%NZDUSD-0.61%AUDNZD-0.53%EURUSD-0.52%USDJPY+0.49%AUDCAD-0.48%PLNJPY+0.44%GBPTRY+0.41%NOKJPY+0.34%CHFJPY-0.34%EURCHF+0.34%SGDJPY+0.33%GBPHKD+0.32%AUDCHF-0.30%GBPMXN-0.28%USDTRY+0.28%NZDCHF+0.27%CADJPY-0.19%CADCHF+0.18%GBPZAR+0.18%EURZAR+0.17%EURCAD+0.17%USDCNH-0.17%USDZAR+0.16%USDILS+0.16%USDMXN+0.15%GBPUSD+0.15%EURNZD+0.10%NZDJPY-0.10%EURSGD+0.09%GBPSGD+0.09%EURNOK+0.09%EURSEK+0.09%CHFSGD+0.08%NZDCAD+0.08%CHFNOK+0.08%USDSGD+0.08%CHFSEK+0.07%AUDSGD+0.07%USDSEK+0.07%USDNOK+0.07%NZDMXN+0.06%AUDNOK+0.06%EURCNH+0.04%USDCOP-0.04%USDHKD+0.04%EURJPY-0.03%USDPLN-0.03%AUDDKK-0.03%USDDKK-0.02%EURPLN-0.01%EURCZK-0.01%EURHKD+0.01%NZDSGD0.00%EURDKK0.00%XAGUSD+0.56%GAGUSD+0.56%HG1-0.36%USOIL-0.25%XPTUSD-0.23%S1-0.21%W1+0.15%C1+0.13%COTTON+0.09%XAUUSD+0.08%GAUUSD+0.08%XNGUSD-0.08%BTCUSD-0.16%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.98%ZECUSDT+0.20%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.86%XLMUSD+2.50%BCHUSDT-0.35%UNIUSD-0.16%LTCUSD+0.07%SUIUSD+2.15%HBARUSDT+1.57%TONUSD+15.77%TAOUSDT+0.01%AAVEUSD-2.54%DOTUSDT+2.78%ICPUSDT-2.19%ONDOUSDT+0.77%WLDUSDT+10.51%ARBUSDT-0.37%JUPUSDT-0.81%ATOMUSDT+1.10%INJUSDT-3.27%STXUSDT+18.33%FETUSDT+3.24%SEIUSDT+0.33%PYTHUSDT-2.99%TIAUSDT-0.52%IMXUSDT+0.97%GRTUSDT-0.30%OPUSDT-0.24%WIFUSDT+3.04%IOTAUSDT+3.16%POLUSDT-4.48%AXSUSDT+0.67%FARTCOINUSDT-0.15%EOSUSDT+3.86%DYDXUSDT+3.30%GALAUSDT+4.75%ORDIUSDT+1.19%NOTUSDT+1.55%RONINUSDT+0.06%
VA

Vaxcyte, Inc. (PCVX)

NASDAQ • Healthcare

$56.9
+$0.21 (+0.4%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$57
Day Range$56.13 - $57.51
Avg. Volume (3M)1.4M
Market Cap$8.2B
52 Week Range
$37.69$65
Next EarningsIn 33 daysNov 3, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$1B
EPS (TTM)
-$7.64
ROA (TTM)
-33.91%
Current Ratio
5.72

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-17.7%Q1 2026-$1.8
-29.4%Q2 2026-$2.3
+4.4%Q3 2026-$1.97
Next

Nov 3

in 33 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +4.4%

Vaxcyte, Inc. topped EPS consensus in the fiscal second quarter of 2026, with EPS of -$1.97 versus a -$2.06 estimate, +4.4%, in preliminary results reported August 5, 2026. The quarter also showed an operating loss of about $302.8 million and a net loss of about $284.3 million, with net income down 70.7% from a loss of $166.6 million a year ago and EPS down 61.5% from -$1.22. Operating cash flow was negative about $513.1 million. Next-period consensus calls for EPS of -$2.12 on revenue of $12.5 million.

View full earnings history

About Vaxcyte, Inc.

Vaxcyte, Inc. trades on the NASDAQ as PCVX and operates in biotechnology within the healthcare sector. The company is a clinical development-stage vaccine maker that develops protein-based candidates to prevent or manage bacterial infectious diseases, rather than a commercial drug business with product revenue.

Name
Vaxcyte, Inc.
CEO
Grant E. Pickering
Website
vaxcyte.com
Industry
Healthcare
Year Founded
2013
Employees
507

Today's Snapshot

AI-generated

PCVX closed slightly higher at 56.90, while its sector was weaker.

Trading Volume

Below 10d avg (1.6M)

1.4M

vs S&P 500 Today

Moderate Outperformance

+0.18%

Updated: September 30, 2026 at 20:17 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
PCVX's technical picture leans bearish as short- and medium-term moving averages sit above the current price while the stock remains modestly above its 100/ and 200-day averages, suggesting recent weakness inside a longer-term base. Momentum readings are soft, with MACD and CCI in negative territory and RSI below the midpoint, while ADX indicates only a mild trend, so directional conviction is limited. Volatility is moderate and ATR shows typical intraday range, and on-balance volume is positive, implying some accumulation despite price pressure. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$54.24 - $58.36
    Sell
  • RSI (14)43.58
    Neutral
  • Stochastic %K (14, 3, 3)34.27
    Neutral
  • MACD Level (12, 26)-0.65
    Sell

Peers & Related Assets

KRYSKrystal Biotech, Inc.
$332.56-0.8%
ARWRArrowhead Pharmaceuticals, Inc.
$65.45-1.2%
CRNXCrinetics Pharmaceuticals, Inc.
$84.950.0%
TGTXTG Therapeutics, Inc.
$55.78-0.7%
ALKSAlkermes plc
$40.52-0.7%
PTCTPTC Therapeutics, Inc.
$64.78-0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.